Evidence map›Paper›PMID 37890392›Full record

ArticleThe International journal on drug policy2023

Development of a systematic social observation tool for monitoring use of harm reduction supplies.

Elizabeth D Nesoff, Shoshana V Aronowitz, Adam J Milam, C Debra M Furr-Holden

Abstract read
In one paragraph

Article in The International journal on drug policy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elizabeth D NesoffUniversity of Pennsylvania Perelman School of Medicine; Department of Biostatistics, Epidemiology, and Informatics; 423 Guardian Dr, Philadelphia, PA 19104, USA. Electronic address: enesoff@upenn.edu.
Shoshana V AronowitzUniversity of Pennsylvania School of Nursing; Department of Family and Community Health; 418 Curie Boulevard, Philadelphia, PA 19104, USA.
Adam J MilamMayo Clinic; Department of Anesthesiology and Perioperative Medicine; 5777 E. Mayo Blvd, Phoenix, AZ 85054, USA.
C Debra M Furr-HoldenNYU School of Global Public Health; Department of Epidemiology; 708 Broadway, New York, NY 10003, USA.

Funding

CE19-001, The Penn Injury Science CenterR49CE003083 · CE · UNIVERSITY OF PENNSYLVANIA · PI MEISEL, ZACHARY FRANKLIN · 2018 to 2023
$4.4M
Neighborhoods, Mental Health, and the Prevention of Opioid Overdose: A Mixed Methods ApproachK01DA049900 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI NESOFF, ELIZABETH · 2020 to 2024
$851k
ACL HHS R49CE003083NCIPC CDC HHS R49 CE003083NIDA NIH HHS K01 DA049900
6 · The paper itself

Abstract

backgroundHarm reduction services such as safer injection supply distribution are essential to reducing morbidity and mortality among people who use drugs (PWUD); however, local use of harm reduction supplies (e.g., tourniquets, saline solution) is difficult to routinely and systematically monitor. The purpose of this study was to develop and validate a systematic social observation tool designed to assess use of harm reduction supplies at the street block level.

methodsData collection took place on a random sample of 150 blocks located throughout the Kensington neighborhood of North Philadelphia from November 2021 to January 2022. We measured inter-rater reliability by two-way mixed-effects intra-class correlation coefficients (ICC) with the consistency agreement definition and internal consistency reliability using Cronbach's alpha and McDonald's omega. Exploratory factor analysis with principal component extraction and promax rotation assessed internal consistency. We validated scales against locations of public syringe disposal boxes, a proxy measure for areas of concentrated drug use, using logistic regression.

resultsNaloxone canisters, syringe caps, saline and sterile water solution bottles showed the highest reliability (ICC≥0.7). Items also showed high internal consistency (alpha, omega>0.7). Exploratory factor analysis identified one, three-item scale with high internal consistency: syringe caps, vials, and baggies (alpha = 0.85; omega = 0.85)-all supplies used concurrently with drug injection but not discarded in syringe disposal boxes. Drug use (OR = 1.78, 95 % CI = (1.48, 2.23)), harm reduction (OR = 3.53, 95 % CI = (2.20, 6.12)), and EFA scales (OR = 1.85, 95 %CI = (1.51, 2.34)) were significantly and positively associated with being within walking distance (≤0.25 miles or 0.4 km) of a syringe disposal box.

conclusionThis study provides an efficient tool with high reliability and validity metrics to assess community uptake of harm reduction supplies designed for use by community organizations, policy makers, or other groups providing resources to PWUD.

Indexed as

Harm ReductionSubstance-Related DisordersHumansNaloxoneReproducibility of ResultsSurveys and QuestionnairesNaloxoneDrug useHarm reductionNaloxoneNeighborhoodSyringeSystematic social observation

Identifiers

PMID37890392
PMCPMC10842406

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.